February Cardiometabolic Risk Assessment Initiative

Cardiovascular risk is closely tied to metabolic health, including lipid levels, inflammatory markers, insulin resistance, and advanced cardiovascular biomarkers.

This month, we are offering structured cardiometabolic assessment panels with individualized interpretation and recommendations.

Wegovy® (semaglutide) has received FDA approval for reducing the risk of major adverse cardiovascular events in certain adults with established cardiovascular disease and overweight or obesity, when used in conjunction with standard cardiovascular care. Individual eligibility and risk factors must be evaluated by a qualified healthcare provider.

Packages

Heart Essentials Panel
$199

Includes:

• Lipid Panel
• Apolipoprotein B (ApoB)
• Lipoprotein (a)
• hs-CRP
• Hemoglobin A1c
• Written cardiovascular risk interpretation + recommendations

Advanced Cardiometablic Panel
$329

Includes:

Everything in Essentials PLUS:

• OmegaCheck
• Homocysteine
• GGT
• Ferritin

Includes written interpretation + recommendations.

Executive Heart Risk Panel
$449

Everything in Advanced PLUS:

• CBC
• 20-minute telehealth cardiovascular risk review visit
• Written structured heart risk summary

Insurance Options

Patients may choose to use insurance for standard laboratory testing. Coverage varies by plan, and advanced cardiovascular markers are often not included.

Self-pay panels offer bundled pricing, convenience, and access to advanced markers commonly excluded by insurance.

Not Sure Where to Start?

If you are considering medical weight management in addition to cardiometabolic lab screening, our Medical Weight Loss Qualification Quiz can help determine whether structured care may be appropriate.

This is a preliminary screening tool and does not replace individualized medical evaluation.

Begin the Qualification Assessment